Cite
HARVARD Citation
McCarthy, E. et al. (2018). Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register. Rheumatology. pp. 470-479. [Online].